• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Championing Change

Championing Change

by Michael Schubert, PhD | Mar 25, 2024 | Essential, Lab Industry Advisor, Legislation-lca

How clinical laboratory professionals can advocate for legislative and regulatory improvements

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Expert Q&A: What’s New with PAMA and SALSA?

Expert Q&A: What’s New with PAMA and SALSA?

by Rachel Muenz | Mar 25, 2024 | Essential, Lab Industry Advisor, Legislation-lca, PAMA-lir

Joyce Gresko, partner at Alston & Bird, discusses the latest on PAMA and what will likely need to happen for SALSA to pass in 2024.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Year in Review: The 8 Most Important Lab Compliance Stories of 2023

Year in Review: The 8 Most Important Lab Compliance Stories of 2023

by Glenn S. Demby | Jan 9, 2024 | Elite, Inside the Lab Industry-lir, Lab Industry Advisor

Though things appeared status quo in 2023, last year may prove to be a turning point for the laboratory industry.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
The Future of Laboratory-Developed Tests

The Future of Laboratory-Developed Tests

by Michael Schubert, PhD | Jan 2, 2024 | Essential, FDA-lca, Lab Industry Advisor, LDTs-lir, Legislation-lca

Comments on the FDA’s proposed rule to regulate LDTs as in vitro diagnostic devices reveal mixed reactions.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
AI in Healthcare: What Do Recent Developments Mean for Labs?

AI in Healthcare: What Do Recent Developments Mean for Labs?

by Rachel Muenz | Jan 2, 2024 | Essential, Inside the Lab Industry-lir, Lab Industry Advisor, Legislation-lca

Genialis CEO and co-founder Rafael Rosengarten, PhD, discusses key 2023 AI developments and what they could mean for laboratories.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com